BRIDGEWATER, N.J. , (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today the pricing of its public offering of 6,000,000 ordinary shares at a price to the public of $5.00 per share.
Who owns osmotica Pharmaceuticals?
Conference Call
-------------------------
International
Conference ID
Webcast (live and replay)
Is osmotica Pharmaceuticals a buy?
Osmotica Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
Is osmotica a public company?
Osmotica Pharmaceuticals is listed on the NASDAQ Global Market and traded under the ticker symbol OSMT.
When was osmotica founded?
Osmotica Pharmaceuticals was founded in 2000.
Who owns Alora Pharmaceuticals?
Conference Call
----------------
Time
Toll free (U.S.)
International
Conference ID